Pharmaceuticals by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
TG Therapeutics leads the 61 pharmaceuticals ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- TG Therapeutics19.0%
- Median
- 5.47%
- Combined market value
- TRY 257.42T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | TG TherapeuticsTGTX · Health Care | 19.0% | TRY 489.2B | TRY 3,236.49 | 2.33% up | 107% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | TRY 412.6B | TRY 5,951.47 | 1.19% up | 13% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | TRY 250B | TRY 4,439.39 | 1.20% up | 113% up | ||
| 4 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | TRY 414.2B | TRY 6,346.64 | 0.93% up | 46% up | ||
| 5 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | TRY 434.1B | TRY 15,531.32 | 0.94% up | 61% up | ||
| 6 | CytokineticsCYTK · Health Care | 12.9% | TRY 365.8B | TRY 2,625.71 | 0.79% up | 20% down | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | TRY 226.7B | TRY 1,361.27 | 0.11% up | 64% down | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | TRY 299.3B | TRY 14,963.66 | 0.98% up | 43% up | ||
| 9 | Spyre TherapeuticsSYRE · Health Care | 12.2% | TRY 462.6B | TRY 4,871.38 | 2.96% up | 286% up | ||
| 10 | AlkermesALKS · Health Care | 11.7% | TRY 392B | TRY 2,332.67 | 1.76% up | 58% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | TRY 229.4B | TRY 2,095.37 | 1.18% down | 88% up | ||
| 12 | BridgeBio PharmaBBIO · Health Care | 10.7% | TRY 764.8B | TRY 3,925.95 | 1.35% up | 17% up | ||
| 13 | ErascaERAS · Health Care | 10.6% | TRY 239.1B | TRY 681.39 | 2.74% down | 403% up | ||
| 14 | Cogent BiosciencesCOGT · Health Care | 10.0% | TRY 252.1B | TRY 1,448.78 | 3.14% up | 20% down | ||
| 15 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | TRY 301B | TRY 4,610.38 | 0.59% down | 31% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | 9.96% | TRY 243.8B | TRY 2,539.71 | 1.46% down | 44% up | ||
| 17 | Oruka TherapeuticsORKA · Health Care | 9.53% | TRY 332.9B | TRY 4,908.45 | 1.04% up | 241% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | 9.31% | TRY 255.7B | TRY 3,060.47 | 0.53% up | 20% down | ||
| 19 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | TRY 490.9B | TRY 21,130.50 | 0.72% down | 24% down | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | TRY 790B | TRY 12,307.44 | 1.38% up | 37% up | ||
| 21 | Corcept TherapeuticsCORT · Health Care | 8.34% | TRY 379.9B | TRY 3,471.02 | 1.78% down | 8% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | TRY 309.8B | TRY 2,191.45 | 1.07% up | 10% up | ||
| 23 | VeradermicsMANE · Health Care | 8.03% | TRY 266.8B | TRY 6,322.68 | 0.22% down | 233% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | TRY 587B | TRY 3,030.46 | 2.69% up | 11% up | ||
| 25 | Definium TherapeuticsDFTX · Health Care | 7.02% | TRY 200.9B | TRY 1,467.69 | 0.95% down | 169% up | ||
| 26 | Elanco Animal HealthELAN · Health Care | 6.59% | TRY 669.3B | TRY 1,339.08 | 2.71% up | 20% up | ||
| 27 | InsmedINSM · Health Care | 6.42% | TRY 1.34T | TRY 6,112.36 | 0.55% down | 40% down | ||
| 28 | Roivant SciencesROIV · Health Care | 6.28% | TRY 1.43T | TRY 1,976.09 | 1.21% up | 90% up | ||
| 29 | Axsome TherapeuticsAXSM · Health Care | 6.20% | TRY 355.6B | TRY 6,760.97 | 1.40% down | 7% down | ||
| 30 | Legend BiotechLEGN · Health Care | 6.13% | TRY 159.9B | TRY 824.13 | 1.43% up | 42% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | TRY 382.5B | TRY 4,868.10 | 1.48% up | 126% up | ||
| 32 | Summit TherapeuticsSMMT · Health Care | 5.28% | TRY 438.5B | TRY 548.24 | 1.87% up | 36% down | ||
| 33 | ABIVAXABVX · Health Care | 4.70% | TRY 369.7B | TRY 4,222.77 | 1.98% up | 27% down | ||
| 34 | Ascendis PharmaASND · Health Care | 4.57% | TRY 899.1B | TRY 13,706.79 | 0.21% up | 28% up | ||
| 35 | United TherapeuticsUTHR · Health Care | 4.31% | TRY 1.24T | TRY 29,037.13 | 1.43% down | 23% up | ||
| 36 | ZoetisZTS · Health Care | 4.12% | TRY 1.73T | TRY 4,252.28 | 0.99% up | 29% down | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | TRY 1.04T | TRY 7,782.05 | 1.41% down | 66% down | ||
| 38 | Belite BioBLTE · Health Care | 3.40% | TRY 324.9B | TRY 7,999.94 | 0.57% up | 31% up | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | TRY 379.9B | TRY 1,090.43 | 2.37% up | 83% up | ||
| 40 | ViatrisVTRS · Health Care | 3.07% | TRY 1.19T | TRY 1,039.99 | 0.83% up | 96% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | TRY 629.9B | TRY 755.58 | 1.29% up | 5% up | ||
| 42 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | TRY 2.5T | TRY 2,146.06 | 0.16% down | 74% up | ||
| 43 | PfizerPFE · Health Care | 2.36% | TRY 8.12T | TRY 1,423.81 | 0.84% down | 14% up | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | 2.29% | TRY 6.2T | TRY 3,030.96 | 2.05% down | 34% up | ||
| 45 | Royalty PharmaRPRX · Health Care | 2.27% | TRY 1.99T | TRY 3,459.92 | 0.12% down | 78% up | ||
| 46 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | TRY 5.01T | TRY 48,423.29 | 0.24% up | 36% up | ||
| 47 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | TRY 6.85T | TRY 27,029.26 | 0.32% up | 27% up | ||
| 48 | GenmabGMAB · Health Care | 1.57% | TRY 1.61T | TRY 2,605.03 | 0.60% down | 70% up | ||
| 49 | BeOne MedicinesONC · Health Care | 1.40% | TRY 2.34T | TRY 20,470.04 | 1.79% down | 17% up | ||
| 50 | Abbott LaboratoriesABT · Health Care | 1.10% | TRY 9.13T | TRY 5,270.33 | 0.21% down | 17% down | ||
| 51 | Merck & CoMRK · Health Care | 1.08% | TRY 17.45T | TRY 7,076.45 | 2.14% down | 51% up | ||
| 52 | AbbVieABBV · Health Care | 0.89% | TRY 25.7T | TRY 14,539.12 | 1.55% down | 26% up | ||
| 53 | GrifolsGRFS · Health Care | 0.88% | TRY 293.8B | TRY 431.73 | 0.81% down | 1% up | ||
| 54 | Novo NordiskNVO · Health Care | 0.87% | TRY 8.88T | TRY 2,015.43 | 1.82% down | 17% down | ||
| 55 | Eli LillyLLY · Health Care | 0.81% | TRY 62.8T | TRY 70,507.54 | 1.24% down | 35% up | ||
| 56 | GSKGSK · Health Care | 0.81% | TRY 4.95T | TRY 2,471.63 | 0.48% down | 6% up | ||
| 57 | Johnson & JohnsonJNJ · Health Care | 0.71% | TRY 33.45T | TRY 13,894.92 | 1.15% down | 38% up | ||
| 58 | SanofiSNY · Health Care | 0.51% | TRY 5.74T | TRY 2,391.68 | 0.23% down | 4% down | ||
| 59 | NovartisNVS · Health Care | 0.24% | TRY 14.93T | TRY 7,905.62 | 1.50% down | 25% up | ||
| 60 | AstraZenecaAZN · Health Care | 0.20% | TRY 14.06T | TRY 9,063.64 | 1.41% down | 2% up | ||
| 61 | Takeda PharmaceuticalTAK · Health Care | 0.10% | TRY 3.45T | TRY 1,079.84 | 1.06% down | 54% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 50.4362 TRY).
Questions and answers
Which pharmaceuticals rank first by short interest?
TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 61 pharmaceuticals ranked by short interest as of the 30 Oct 2026 settlement date.
How many pharmaceuticals are in this ranking?
61 are ranked by short interest.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by short interest have a combined market value of TRY 257.42T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceuticals by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.